Steven Gillis

Steven Gillis

Net worth: 821 664 $ as of 30/05/2026

73 year
Health Technology
Finance
Commercial Services

Profile

Steven H.
Gillis
founded Vilya, Inc. in 2022, Immunex Corp.
in 1981, where he worked as Director, Chief Executive & Scientific Officer from 1981 to 1994, and Corixa Corp.
in 1994, where he worked as Chairman & Chief Executive Officer from 1999 to 2005.
Dr. Gillis also currently works at HiberCell, Inc., as Chairman & Chief Executive Officer from 2025, Theraclone Sciences, Inc., as Chairman from 2011, eGenesis, Inc., as Chairman, and various other companies.
Dr. Gillis also formerly worked at Emergent Product Development Seattle, as Executive Chairman, President & CEO from 2009 to 2010, Allozyne, Inc., as Executive Chairman, Viral Logic Systems Technology Corp., as Chairman in 2009, and various other companies.
Dr. Gillis received his doctorate degree in 1978 from Dartmouth College and undergraduate degree in 1975 from Williams College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
17/03/2026 25,557 ( 0% ) 821 664 $ 30/05/2026

Steven Gillis active positions

CompaniesPositionStart
TAKEDA PHARMACEUTICAL COMPANY LIMITED Director/Board Member 31/12/2018
Director/Board Member -
Director/Board Member -
Director/Board Member -
Chairman -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -

Former positions of Steven Gillis

CompaniesPositionEnd
░░░ ░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░ ░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Steven Gillis's experience

Training of Steven Gillis

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

63

1st degree connections

59

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies59

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Retail Trade

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Finance

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Finance

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Retail Trade

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!